Results 1 to 10 of about 48,993 (152)
Some of the next articles are maybe not open access.
Streptozotocin- and Alloxan-Diabetes in Mice
European Journal of Pharmacology, 1969Abstract In non-fasted albino (NMRI) mice intravenous diabetogenic doses were 200 mg/kg body weight of streptozotocin or 70 mg/kg of alloxan monohydrate. Differences in diabetes development were as follows. Maximal blood glucose levels during the phase of acute hyperglycaemia were observed 120 min after streptozotocin and 45 min after alloxan ...
Claus Rerup
exaly +3 more sources
Protection Against Streptozotocin-Induced Diabetes by Superoxide Dismutase
Diabetologia, 1980A E Slonim, I M Burr
exaly
Relative Importance of Transport and Alkylation for Pancreatic Beta-Cell Toxicity of Streptozotocin
Diabetologia, 2000Markus Tiedge, M Elsner
exaly
Increase of Intestinal Brush Border Hydrolases in Mucosa of Streptozotocin-Diabetic Rats
Diabetologia, 1972Wolfgang F Caspary, Werner Creutzfeldt
exaly
Histopathological Changes in the Placenta of Streptozotocin Induced Diabetic Rats
Diabetologia, 1974R Prager, E Liban, A Abramovici
exaly
Streptozotocin, but Not Alloxan, Induces DNA Repair Synthesis in Mouse Pancreatic Islets in Vitro
Diabetologia, 1983I Swenne, S Sandler
exaly
Biosynthesis and Hypoglycemic Potential of Chitosan Nano-selenium In Experimentally Induced Diabetic In Rats [PDF]
The present study investigated the effects of selenium nanoparticles (SeNPs) at dose 2 mg/kg body weight in streptozotocin (STZ) induced diabetes in a rat model at dose 50 mg/kg body weight.
omayma Abo zaid +2 more
doaj +1 more source

